Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Supplement—December 2025

SUPPLEMENT ISSUE
Supplement

Functional Limitations and Illness-Related Absenteeism among School-Aged Children with and without Long COVID, United States, 2022–2023

Nicole D. FordComments to Author , Regina M. Simeone, Caroline Pratt, and Sharon Saydah
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure

Adjusted odds ratios from a study of functional limitations and illness-related chronic absenteeism among school-aged children with and without long COVID, United States, 2022–2023. Graph shows adjusted odds ratios (dots) and 95% CIs (whiskers) for chronic absence from school for health reasons among children with prior COVID-19 illness comparing children who did and did not have long COVID. The study examined 4,587 school-aged children (5–17 years) who had COVID-19 illness identified through the National Health Interview Survey, 2022–2023 (5,6). Chronic absence from school for health reasons was defined as missing >18 days of school because of illness or injury (compared with 0–17 days) during the 12 months preceding the survey. The minimally adjusted model controls for race and Hispanic ethnicity and parental education. Chronic health conditions included asthma, prediabetes, and diabetes. Neurodevelopmental conditions include autism, attention-deficit hyperactivity disorder, intellectual disability, learning disability, and developmental delay.

Figure. Adjusted odds ratios from a study of functional limitations and illness-related chronic absenteeism among school-aged children with and without long COVID, United States, 2022–2023. Graph shows adjusted odds ratios (dots) and 95% CIs (whiskers) for chronic absence from school for health reasons among children with prior COVID-19 illness comparing children who did and did not have long COVID. The study examined 4,587 school-aged children (5–17 years) who had COVID-19 illness identified through the National Health Interview Survey, 2022–2023 (5,6). Chronic absence from school for health reasons was defined as missing >18 days of school because of illness or injury (compared with 0–17 days) during the 12 months preceding the survey. The minimally adjusted model controls for race and Hispanic ethnicity and parental education. Chronic health conditions included asthma, prediabetes, and diabetes. Neurodevelopmental conditions include autism, attention-deficit hyperactivity disorder, intellectual disability, learning disability, and developmental delay.

Main Article

References
  1. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on the Long-Term Health Effects Stemming from COVID-19 and Implications for the Social Security Administration. Long-term health effects of COVID-19: disability and function following SARS-CoV-2 infection. Spicer CM, Chu BX, Volberding PA, editors. Washington: National Academies Press; 2024.
  2. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Board on Health Sciences Policy; Committee on Examining the Working Definition for Long COVID. A long COVID definition: a chronic, systemic disease state with profound consequences. Goldowitz I, Worku T, Brown L, Fineberg HV, editors. Washington: National Academies Press; 2024.
  3. Ford  ND, Vahratian  A, Pratt  CQ, Yousaf  AR, Gregory  CO, Saydah  S. Long COVID prevalence and associated activity limitation in US children. JAMA Pediatr. 2025;179:471–3.PubMedGoogle Scholar
  4. MacLean  A, Wild  C, Hunt  K, Nettleton  S, Skea  ZC, Ziebland  S. Impact of Long Covid on the school experiences of children and young people: a qualitative study. BMJ Open. 2023;13:e075756.PubMedGoogle Scholar
  5. National Center for Health Statistics. National Health Interview Survey 2022 survey description. Hyattsville (MD): National Center for Health Statistics; 2023.
  6. National Center for Health Statistics. National Health Interview Survey 2023 survey description. Hyattsville (MD): National Center for Health Statistics; 2024.
  7. Washington Group on Disability Statistics. The Washington Group/UNICEF child functioning module (CFM)—ages 5–17 years [cited 2024 Aug 19]. https://nhis.ipums.org/nhis/resources/Washington_Group_Questionnaire__5_-_WG-UNICEF_Child_Functioning_Module__ages_5-17_.pdf
  8. Parker  JD, Talih  M, Malec  DJ, Beresovsky  V, Carroll  M, Gonzalez  JF Jr, et al. National Center for Health Statistics data presentation standards for proportions; vital statistics series 2, no. 175. Hyattsville (MD): National Center for Health Statistics: 2017.
  9. US Department of Education. Chronic absenteeism [cited 2025 June 2]. https://www.ed.gov/teaching-and-administration/supporting-students/chronic-absenteeism
  10. Vahratian  A, Adjaye-Gbewonyo  D, Lin  JMS, Saydah  S. Long COVID in children: United States, 2022; NCHS data brief no. 479. Hyattsville (MD): National Center for Health Statistics; 2023.
  11. Ingram  D, Franco  S. 2013 NCHS urban-rural classification scheme for counties; vital health statistics, series 2, no. 166. Hyattsville (MD): National Center for Health Statistics; 2014.
  12. Centers for Disease Control and Prevention. Isolation and precautions for people with COVID-19 [cited 2024 Nov 27]. https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/isolation.html
  13. Popoli  DM, Burns  TG, Meehan  WP III, Reisner  A; Children’s Health of Atlants. CHOA concussion consensus: establishing a uniform policy for academic accommodations. Clin Pediatr (Phila). 2014;53:217–24.PubMedGoogle Scholar
  14. Wolraich  ML, Hagan  JF Jr, Allan  C, Chan  E, Davison  D, Earls  M, et al.; SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144:e20192528.PubMedGoogle Scholar
  15. Rao  S, Gross  RS, Mohandas  S, Stein  CR, Case  A, Dreyer  B, et al. Postacute sequelae of SARS-CoV-2 in children. Pediatrics. 2024;153:e2023062570.PubMedGoogle Scholar
  16. Lopez-Leon  S, Wegman-Ostrosky  T, Ayuzo Del Valle  NC, Perelman  C, Sepulveda  R, Rebolledo  PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950.PubMedGoogle Scholar
  17. Delogu  AB, Aliberti  C, Birritella  L, De Rosa  G, De Rose  C, Morello  R, et al. Autonomic cardiac function in children and adolescents with long COVID: a case-controlled study. Eur J Pediatr. 2024;183:2375–82.PubMedGoogle Scholar
  18. Cocciolillo  F, Di Giuda  D, Morello  R, De Rose  C, Valentini  P, Buonsenso  D. Orbito-frontal cortex hypometabolism in children with post-COVID condition (long COVID): a preliminary experience. Pediatr Infect Dis J. 2022;41:663–5.PubMedGoogle Scholar
  19. Baldi  F, De Rose  C, Mariani  F, Morello  R, Raffaelli  F, Valentini  P, et al. Cardiopulmonary exercise testing in children with long COVID: a case-controlled study. Pediatr Infect Dis J. 2024;43:795–802.PubMedGoogle Scholar
  20. Johnson  SB, Spin  P, Connolly  F, Stein  M, Cheng  TL, Connor  K. Asthma and attendance in urban schools. Prev Chronic Dis. 2019;16:E148.PubMedGoogle Scholar
  21. Glaab  LA, Brown  R, Daneman  D. School attendance in children with Type 1 diabetes. Diabet Med. 2005;22:421–6.PubMedGoogle Scholar
  22. Badenoch  JB, Rengasamy  ER, Watson  C, Jansen  K, Chakraborty  S, Sundaram  RD, et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 2021;4:fcab297.PubMedGoogle Scholar
  23. Becker  JH, Lin  JJ, Doernberg  M, Stone  K, Navis  A, Festa  JR, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4:e2130645.PubMedGoogle Scholar
  24. Leeb  RT, Danielson  ML, Claussen  AH, Robinson  LR, Lebrun-Harris  LA, Ghandour  R, et al. Trends in mental, behavioral, and developmental disorders among children and adolescents in the US, 2016–2021. Prev Chronic Dis. 2024;21:E96.PubMedGoogle Scholar
  25. Substance Abuse and Mental Health Services Administration. Identification and management of mental health symptoms and conditions associated with long COVID. Publication no. PEP23-06-05-007. Rockville (MD): The Administration; 2023.
  26. Camporesi  A, Morello  R, La Rocca  A, Zampino  G, Vezzulli  F, Munblit  D, et al. Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study. EClinicalMedicine. 2024;76:102815.PubMedGoogle Scholar
  27. Heslin  KP, Haruna  A, George  RA, Chen  S, Nobel  I, Anderson  KB, et al. Association between ADHD and COVID-19 infection and clinical outcomes: a retrospective cohort study from electronic medical records. J Atten Disord. 2023;27:169–81.PubMedGoogle Scholar
  28. Centers for Disease Control and Prevention. People with certain medical conditions and COVID-19 risk factors [cited 2024 May 14]. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
  29. Hall  JP, Kurth  NK, McCorkell  L, Goddard  KS. Long COVID among people with preexisting disabilities. Am J Public Health. 2024;114:1261–4.PubMedGoogle Scholar
  30. Zheng  YB, Zeng  N, Yuan  K, Tian  SS, Yang  YB, Gao  N, et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J Infect Public Health. 2023;16:660–72.PubMedGoogle Scholar
  31. Kompaniyets  L, Bull-Otterson  L, Boehmer  TK, Baca  S, Alvarez  P, Hong  K, et al. Post–COVID-19 symptoms and conditions among children and adolescents—United States, March 1, 2020–January 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:993–9.PubMedGoogle Scholar
  32. Danielson  ML, Bohm  MK, Newsome  K, Claussen  AH, Kaminski  JW, Grosse  SD, et al. Trends in stimulant prescription fills among commercially insured children and adults—United States, 2016–2021. MMWR Morb Mortal Wkly Rep. 2023;72:327–32.PubMedGoogle Scholar
  33. Chua  KP, Volerman  A, Zhang  J, Hua  J, Conti  RM. Antidepressant dispensing to US adolescents and young adults: 2016–2022. Pediatrics. 2024;153:e2023064245.PubMedGoogle Scholar
  34. Koonce  RM, Martin  BC. The association between suspected long-COVID and stimulant prescribing in the United States. Psychiatry Res. 2024;331:115686.PubMedGoogle Scholar
  35. Vernon  SD, Zheng  T, Do  H, Marconi  VC, Jason  LA, Singer  NG, et al.; NIH Researching COVID to Enhance Recovery (RECOVER) Consortium. Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: a report from the observational RECOVER-Adult study. J Gen Intern Med. 2025;40:1085–94.PubMedGoogle Scholar
  36. Grach  SL, Seltzer  J, Chon  TY, Ganesh  R. Diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome. Mayo Clin Proc. 2023;98:1544–51.PubMedGoogle Scholar
  37. American Federation of Teachers. Chronic absenteeism 2016 [cited 2024 Nov 25]. https://www.aft.org/childrens-health-safety-and-well-being/childrens-access-care/chronic-absenteeism
  38. Dee  TS. Higher chronic absenteeism threatens academic recovery from the COVID-19 pandemic. Proc Natl Acad Sci U S A. 2024;121:e2312249121.PubMedGoogle Scholar
  39. Black  LI, Elgaddal  N. Chronic school absenteeism for health-related reasons among children ages 5‒17 years: United States, 2022. NCHS data brief, no. 498. Hyattsville (MD): National Center for Health Statistics; 2024.
  40. Wikel  K, Markelz  AM. Chronic health conditions, school attendance, and socioeconomic factors: a literature review. J Spec Educ Apprenticeship. 2023;12:9. DOIGoogle Scholar
  41. Attendance Works. Chronic absence: 3 tiers of intervention [cited 2025 Feb 19]. https://www.attendanceworks.org/chronic-absence/addressing-chronic-absence/3-tiers-of-intervention/
  42. Kearney  CA, Dupont  R, Fensken  M, Gonzálvez  C. School attendance problems and absenteeism as early warning signals: review and implications for health-based protocols and school-based practices. Front Educ (Lausanne). 2023;8:1253595. DOIGoogle Scholar
  43. Malone  LA, Morrow  A, Chen  Y, Curtis  D, de Ferranti  SD, Desai  M, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of postacute sequelae of SARS-CoV-2 infection (PASC) in children and adolescents. PM R. 2022;14:1241–69.PubMedGoogle Scholar
  44. Howard J, Cloeren M, Vanichkachorn G. Long COVID and occupational medicine practice. J Occup Environ Med. 2024;66:1–5.
  45. Ziauddeen  N, Gurdasani  D, O’Hara  ME, Hastie  C, Roderick  P, Yao  G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PLoS One. 2022;17:e0264331.PubMedGoogle Scholar
  46. Appelman  B, Charlton  BT, Goulding  RP, Kerkhoff  TJ, Breedveld  EA, Noort  W, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15:17.PubMedGoogle Scholar
  47. Lipkin  PH, Okamoto  J; Council on Children with Disabilities; Council on School Health. The Individuals With Disabilities Education Act (IDEA) for Children With Special Educational Needs. Pediatrics. 2015;136:e1650–62.PubMedGoogle Scholar

Main Article

Page created: January 07, 2026
Page updated: January 22, 2026
Page reviewed: January 22, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external